Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig L Leonardi

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Seminars in Cutaneous Medicine and Surgery|August 24, 2016
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|June 1, 2018
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L Leonardi
Managed Care (Langhorne, Pa.)|June 21, 2008
Overview of psoriasis: update on current and emerging treatment optionsCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
Data on the safety of psoriasis therapiesCraig L Leonardi
Dermatologic Clinics|September 29, 2004
Current concepts and review of efalizumab in the treatment of psoriasisCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|June 1, 2018
Small Molecules for PsoriasisCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Small Molecules for PsoriasisCraig L Leonardi
Journal of the American Academy of Dermatology|August 2, 2003
Efalizumab: an overviewCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|August 16, 2016
New Therapies for PsoriasisCraig L Leonardi
Dermatologic Therapy|September 24, 2004
Efalizumab in the treatment of psoriasisCraig L Leonardi
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Seminars in Cutaneous Medicine and Surgery|August 24, 2016
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|June 1, 2018
Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17aCraig L Leonardi
Managed Care (Langhorne, Pa.)|June 21, 2008
Overview of psoriasis: update on current and emerging treatment optionsCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|October 1, 2014
Data on the safety of psoriasis therapiesCraig L Leonardi
Dermatologic Clinics|September 29, 2004
Current concepts and review of efalizumab in the treatment of psoriasisCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|June 1, 2018
Small Molecules for PsoriasisCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|August 16, 2016
Small Molecules for PsoriasisCraig L Leonardi
Journal of the American Academy of Dermatology|August 2, 2003
Efalizumab: an overviewCraig L Leonardi
Seminars in Cutaneous Medicine and Surgery|August 16, 2016
New Therapies for PsoriasisCraig L Leonardi
Dermatologic Therapy|September 24, 2004
Efalizumab in the treatment of psoriasisCraig L Leonardi
Pageof 8